Elsevier

Schizophrenia Research

Volume 195, May 2018, Pages 568-569
Schizophrenia Research

Letter to the Editor
Effects of a nicotinic agonist on the Brief Psychiatric Rating Scale five-factor subscale model in schizophrenia

https://doi.org/10.1016/j.schres.2017.10.016Get rights and content

Section snippets

Acknowledgements

This work was supported by Autism Speaks grant #9699 (ASL) and by NIH grants R01DA14241, R01MH077681 (MRP), and R25MH071584, T32MH1427 (ASL). The funding sources had no role in the design, analysis, or interpretation of the data.

Conflict of interest

WRK is a co-inventor on a University of Florida patent for DMXB-A. The other authors declare no conflicts of interest.

Contributors

ASL designed the study, performed data analysis, and wrote the manuscript. AO, RWB, WRK, and RF performed data analysis and contributed to writing the manuscript. MRP designed the study and contributed to writing the manuscript.

References (10)

There are more references available in the full text version of this article.

Cited by (0)

View full text